AU1661002A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents
Secreted and transmembrane polypeptides and nucleic acids encoding the sameInfo
- Publication number
- AU1661002A AU1661002A AU1661002A AU1661002A AU1661002A AU 1661002 A AU1661002 A AU 1661002A AU 1661002 A AU1661002 A AU 1661002A AU 1661002 A AU1661002 A AU 1661002A AU 1661002 A AU1661002 A AU 1661002A
- Authority
- AU
- Australia
- Prior art keywords
- secreted
- same
- nucleic acids
- acids encoding
- transmembrane polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22989600P | 2000-09-01 | 2000-09-01 | |
US23062100P | 2000-09-05 | 2000-09-05 | |
US23514700P | 2000-09-22 | 2000-09-22 | |
PCT/US2000/030873 WO2001040465A2 (en) | 1999-11-30 | 2000-11-10 | Compositions and methods for the treatment of immune related diseases |
US26187801P | 2001-01-12 | 2001-01-12 | |
US26191001P | 2001-01-16 | 2001-01-16 | |
US26215001P | 2001-01-16 | 2001-01-16 | |
US26193901P | 2001-01-16 | 2001-01-16 | |
US26439501P | 2001-01-25 | 2001-01-25 | |
US26642101P | 2001-02-02 | 2001-02-02 | |
US26762301P | 2001-02-09 | 2001-02-09 | |
PCT/US2001/006520 WO2001068848A2 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US27439901P | 2001-03-09 | 2001-03-09 | |
US28098201P | 2001-04-03 | 2001-04-03 | |
US28212901P | 2001-04-04 | 2001-04-04 | |
US28219901P | 2001-04-04 | 2001-04-04 | |
US29058901P | 2001-05-09 | 2001-05-09 | |
PCT/US2001/017092 WO2001092331A2 (en) | 2000-05-30 | 2001-05-25 | Compositions and methods for the treatment of immune related diseases |
PCT/US2001/017800 WO2001093983A1 (en) | 2000-06-02 | 2001-06-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2001/019692 WO2002000690A2 (en) | 2000-06-23 | 2001-06-20 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
PCT/US2001/021066 WO2002008288A2 (en) | 2000-07-20 | 2001-06-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2001/021735 WO2002008284A2 (en) | 2000-07-20 | 2001-07-09 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
PCT/US2001/027099 WO2002024888A2 (en) | 2000-09-01 | 2001-08-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1661002A true AU1661002A (en) | 2002-04-02 |
Family
ID=27585542
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216610A Abandoned AU2002216610A1 (en) | 2000-09-01 | 2001-08-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU1661002A Pending AU1661002A (en) | 2000-09-01 | 2001-09-19 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216610A Abandoned AU2002216610A1 (en) | 2000-09-01 | 2001-08-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1341814A2 (xx) |
JP (2) | JP4451059B2 (xx) |
AU (2) | AU2002216610A1 (xx) |
CA (2) | CA2421056A1 (xx) |
WO (1) | WO2002024888A2 (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2261335T (pt) | 1998-11-27 | 2017-09-08 | Ucb Pharma Sa | Composições e métodos para aumentar a mineralização óssea |
US20040009535A1 (en) | 1998-11-27 | 2004-01-15 | Celltech R&D, Inc. | Compositions and methods for increasing bone mineralization |
EP1250426A2 (en) * | 1999-12-01 | 2002-10-23 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding same |
US20040132021A1 (en) * | 2000-06-19 | 2004-07-08 | Wendy Balemans | Osteolevin gene polymorphisms |
US7094570B2 (en) | 2003-03-11 | 2006-08-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
AU2002249948B2 (en) | 2001-01-12 | 2007-08-23 | Genetics Institute, Llc | Type 2 cytokine receptor and nucleic acids encoding same |
ATE464320T1 (de) * | 2001-07-19 | 2010-04-15 | Innate Pharma | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) |
US7893218B2 (en) | 2003-06-16 | 2011-02-22 | Stowers Institute For Medical Research | Antibodies that specifically bind SOST peptides |
US20040023356A1 (en) | 2002-06-14 | 2004-02-05 | Robb Krumlauf | Wise/Sost nucleic acid sequences and amino acid sequences |
US7585501B2 (en) | 2002-06-14 | 2009-09-08 | Stowers Institute For Medical Research | Compositions and methods for treating kidney disease |
FR2844713A1 (fr) * | 2002-09-25 | 2004-03-26 | Exonhit Therapeutics Sa | Nouvelle cible de l'angiogenese et utilisations |
WO2004035789A1 (en) * | 2002-10-18 | 2004-04-29 | Lg Life Sciences Ltd. | Gene families associated with cancers |
MEP2808A (xx) | 2003-06-16 | 2010-02-10 | Celltech R & D Inc | Antitijela specifična za sklerositin i metode za povećanje mineralizacije kostiju |
US8003108B2 (en) | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
US7592429B2 (en) | 2005-05-03 | 2009-09-22 | Ucb Sa | Sclerostin-binding antibody |
CL2008002775A1 (es) | 2007-09-17 | 2008-11-07 | Amgen Inc | Uso de un agente de unión a esclerostina para inhibir la resorción ósea. |
WO2011051271A2 (en) | 2009-10-26 | 2011-05-05 | Externautics S.P.A. | Prostate tumor markers and methods of use thereof |
WO2011051280A1 (en) | 2009-10-26 | 2011-05-05 | Externautics S.P.A. | Ovary tumor markers and methods of use thereof |
EP2383578A1 (en) * | 2010-04-30 | 2011-11-02 | Externautics S.p.A. | Tumor marker and methods of use thereof |
EP3195880B1 (en) | 2010-05-14 | 2019-11-27 | Amgen Inc. | High concentration anti-sclerostin antibody formulations |
US9133272B2 (en) | 2011-03-01 | 2015-09-15 | Amgen Inc. | Bispecific binding agents |
JP2014511842A (ja) | 2011-03-25 | 2014-05-19 | アムジエン・インコーポレーテツド | 抗スクレロスチン抗体結晶およびその製剤 |
SI2739311T1 (en) | 2011-08-04 | 2018-07-31 | Amgen Inc. | Method for the treatment of bone defect defects |
AU2012362898B2 (en) | 2011-12-28 | 2017-11-09 | Amgen, Inc. | Method of treating alveolar bone loss through the use of anti-sclerostin antibodies |
CN104619342A (zh) | 2012-07-05 | 2015-05-13 | Ucb医药有限公司 | 骨疾病的治疗 |
UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
WO2014100740A1 (en) | 2012-12-21 | 2014-06-26 | Seattle Genetics, Inc. | Anti-ntb-a antibodies and related compositions and methods |
MA41142A (fr) | 2014-12-12 | 2017-10-17 | Amgen Inc | Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement |
GB201604124D0 (en) | 2016-03-10 | 2016-04-27 | Ucb Biopharma Sprl | Pharmaceutical formulation |
US11466079B2 (en) | 2018-03-30 | 2022-10-11 | Amgen Inc. | C-terminal antibody variants |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
US5824504A (en) * | 1996-09-26 | 1998-10-20 | Elshourbagy; Nabil A. | Human 7-transmembrane receptor and DNA |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
JP2002512517A (ja) * | 1997-03-25 | 2002-04-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
DE19817557A1 (de) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
EP1210418B1 (en) * | 1999-06-02 | 2010-08-18 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
-
2001
- 2001-08-29 CA CA002421056A patent/CA2421056A1/en not_active Abandoned
- 2001-08-29 JP JP2002529483A patent/JP4451059B2/ja not_active Expired - Lifetime
- 2001-08-29 WO PCT/US2001/027099 patent/WO2002024888A2/en active Application Filing
- 2001-08-29 EP EP01985272A patent/EP1341814A2/en not_active Ceased
- 2001-08-29 CA CA002632702A patent/CA2632702A1/en not_active Abandoned
- 2001-08-29 AU AU2002216610A patent/AU2002216610A1/en not_active Abandoned
- 2001-09-19 AU AU1661002A patent/AU1661002A/xx active Pending
-
2006
- 2006-02-01 JP JP2006024604A patent/JP2006223304A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2006223304A (ja) | 2006-08-31 |
CA2421056A1 (en) | 2002-03-28 |
WO2002024888A2 (en) | 2002-03-28 |
EP1341814A2 (en) | 2003-09-10 |
JP2004526412A (ja) | 2004-09-02 |
WO2002024888A3 (en) | 2003-07-03 |
JP4451059B2 (ja) | 2010-04-14 |
CA2632702A1 (en) | 2002-03-28 |
AU2002216610A1 (en) | 2002-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6802801A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU7315001A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU6531101A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU1661002A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL139686A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL188581A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU7573000A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL141535A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
EP1490386A4 (en) | NEW POLYPEPTIDES AND THESE ENCODING NUCLEIC ACIDS | |
AU2002368010A8 (en) | Novel nucleic acids and secreted polypeptides | |
EP1173456A4 (en) | SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING THEM | |
AU2001249394A1 (en) | Secreted proteins and polynucleotides encoding them | |
AU2002367815A8 (en) | Novel nucleic acids and secreted polypeptides | |
AU2001239889A1 (en) | Polypeptides and nucleic acids encoding same | |
KR100514265B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100532172B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100498658B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100528420B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
AU4587101A (en) | Novel human secreted proteins and polynucleotides encoding the same | |
AU2001234896A1 (en) | Novel polypeptides and nucleic acids encoding same | |
IL142673A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU5152700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same |